Insulin glargine

被引：159

作者：

Bolli, GB ^{[1
]}

Owens, DR

机构：

[1] Univ Perugia, Dept Internal Med, I-06126 Perugia, Italy

[2] Cardiff Univ, Diabet Res Unit, Cardiff CF4 4XN, S Glam, Wales

来源：

LANCET | 2000年 / 356卷 / 9228期

关键词：

D O I：

10.1016/S0140-6736(00)02546-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：443 / 445

页数：3

相关论文

共 14 条

[1] The long acting human insulin analog HOE 901:: Characteristics of insulin signalling in comparison to Asp(B10) and regular insulin
Berti, L
Kellerer, M
Bossenmaier, B
Seffer, E
Seipke, G
Häring, HU
[J]. HORMONE AND METABOLIC RESEARCH, 1998, 30 (03) : 123 - 129
[2] Insulin analogues and their potential in the management of diabetes mellitus
Bolli, GB
Di Marchi, RD
Park, GD
Pramming, S
Koivisto, VA
[J]. DIABETOLOGIA, 1999, 42 (10) : 1151 - 1167
[3] Bolli GB, 1999, J PEDIATR ENDOCR MET, V12, P737
[4] Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo
Heinemann, L
Linkeschova, R
Rave, K
Hompesch, B
Sedlak, M
Heise, T
[J]. DIABETES CARE, 2000, 23 (05) : 644 - 649
[5] Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens
Jehle, PM
Micheler, C
Jehle, DR
Breitig, D
Boehm, BB
[J]. LANCET, 1999, 354 (9190) : 1604 - 1607
[6] Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
Kurtzhals, P
Schäffer, L
Sorensen, A
Kristensen, C
Jonassen, I
Schmid, C
Trüb, T
[J]. DIABETES, 2000, 49 (06) : 999 - 1005
[7] Lepore M, 1999, DIABETES, V48, pA97
[8] OWENS DR, 1999, DIABETES CURRENT PER
[9] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION - APPROACH TO ACHIEVING NORMOGLYCAEMIA
PICKUP, JC
KEEN, H
PARSONS, JA
ALBERTI, KGMM
[J]. BRITISH MEDICAL JOURNAL, 1978, 1 (6107) : 204 - 207
[10] Pieber T, 1998, DIABETES, V47, pA62